GlassScriptPhysician profile
Christian S Hanson
NPI 1083684302
$4,276.49
in general payments reported to CMS, 2019-2025
40 companies · none reported in 2025
See the full distribution for Endocrinology, Diabetes & Metabolism
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,497 · 2020: $262 · 2021: $386 · 2022: $859 · 2023: $1,273.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,273.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,272.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $713.91 | 2019-2023 | Jardiance, Lyumjev, Mounjaro |
| Astrazeneca Pharmaceuticals LP | $325.74 | 2019-2021 | |
| Novo Nordisk INC | $298.13 | 2019-2023 | Wegovy, Rybelsus, Ozempic |
| Bayer Healthcare Pharmaceuticals INC. | $220.26 | 2021-2023 | |
| Insulet Corporation | $214.51 | 2020-2023 | Omnipod |
| Alexion Pharmaceuticals, INC. | $187.45 | 2021-2023 | Strensiq |
| Tandem Diabetes Care, INC. | $178.24 | 2019-2023 | T:Slim X2 Insulin Pump With Control-Iq |
| Genentech USA, INC. | $176.55 | 2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $171.32 | 2019-2023 | Jardiance |
| Amgen INC. | $143.24 | 2019-2022 | |
| Antares Pharma, INC. | $140.22 | 2019-2023 | Tlando, Xyosted, Nocdurna |
| Corcept Therapeutics | $127.53 | 2019-2023 | Korlym |
| Amarin Pharma, INC. | $123.60 | 2019-2021 | |
| Abbott Laboratories | $122.42 | 2019-2023 | Freestyle Libre 3 |
| Mannkind Corporation | $112.26 | 2022-2023 | Afrezza |
Show all 40 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christian Hanson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.